Rajesh Vij

1.2k total citations
13 papers, 726 citations indexed

About

Rajesh Vij is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rajesh Vij has authored 13 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rajesh Vij's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Bacterial Genetics and Biotechnology (2 papers). Rajesh Vij is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Bacterial Genetics and Biotechnology (2 papers). Rajesh Vij collaborates with scholars based in United States, France and China. Rajesh Vij's co-authors include James T. Koerber, Charles Eigenbrot, Daniel Kirchhofer, Wěi Li, Paul Moran, Bin Fan, Steven T. Rutherford, Peter A. Smith, Dawei Sun and Kelly M. Storek and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Rajesh Vij

13 papers receiving 699 citations

Peers

Rajesh Vij
Andrew Chen United States
Mireille Vankemmelbeke United Kingdom
Christopher Agnew United States
C. R. Bebbington United Kingdom
Kevin L. Bicker United States
Samuel J. S. Rubin United States
Andrew Chen United States
Rajesh Vij
Citations per year, relative to Rajesh Vij Rajesh Vij (= 1×) peers Andrew Chen

Countries citing papers authored by Rajesh Vij

Since Specialization
Citations

This map shows the geographic impact of Rajesh Vij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Vij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Vij more than expected).

Fields of papers citing papers by Rajesh Vij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Vij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Vij. The network helps show where Rajesh Vij may publish in the future.

Co-authorship network of co-authors of Rajesh Vij

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Vij. A scholar is included among the top collaborators of Rajesh Vij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Vij. Rajesh Vij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Maun, Henry R., Rajesh Vij, Benjamin T. Walters, et al.. (2020). Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge. Nature Communications. 11(1). 6435–6435. 38 indexed citations
2.
Sperinde, Gizette, Meire Bremer, Henry R. Maun, et al.. (2020). Development of a Specific Immunoassay to Selectively Measure Active Tryptase in Airway Samples. Bioanalysis. 12(19). 1377–1388. 3 indexed citations
3.
Zheng, Bing, Shang‐Fan Yu, Geoffrey Del Rosario, et al.. (2018). An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia. Clinical Cancer Research. 25(4). 1358–1368. 49 indexed citations
4.
Vij, Rajesh, Zhonghua Lin, Kellen Schneider, Dhaya Seshasayee, & James T. Koerber. (2018). Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization. PLoS ONE. 13(6). e0197962–e0197962. 7 indexed citations
5.
Slaga, Dionysos, Diego Ellerman, T. Noelle Lombana, et al.. (2018). Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3. Science Translational Medicine. 10(463). 93 indexed citations
6.
Storek, Kelly M., Marcy R. Auerbach, Handuo Shi, et al.. (2018). Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal. Proceedings of the National Academy of Sciences. 115(14). 3692–3697. 117 indexed citations
7.
Storek, Kelly M., Rajesh Vij, Dawei Sun, et al.. (2018). The Escherichia coli β-Barrel Assembly Machinery Is Sensitized to Perturbations under High Membrane Fluidity. Journal of Bacteriology. 201(1). 23 indexed citations
8.
Junttila, Melissa R., Weiguang Mao, Xi Wang, et al.. (2015). Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer. Science Translational Medicine. 7(314). 314ra186–314ra186. 127 indexed citations
9.
Auerbach, Marcy R., Donghong Yan, Rajesh Vij, et al.. (2014). A Neutralizing Anti-gH/gL Monoclonal Antibody Is Protective in the Guinea Pig Model of Congenital CMV Infection. PLoS Pathogens. 10(4). e1004060–e1004060. 36 indexed citations
10.
Bhakta, Sunil, Rajesh Vij, Dara Kallop, et al.. (2013). An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteins. mAbs. 6(1). 95–107. 23 indexed citations
11.
Vitari, Alberto C., Kevin G. Leong, Kim Newton, et al.. (2011). COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 474(7351). 403–406. 138 indexed citations
12.
Mao, Weiguang, Janet Tien, David M. Goldenberg, et al.. (2010). Abstract 4289: Early study on LGR5/GPR49 molecule as a potential colon cancer stem cell target for the antibody conjugated drug treatment. Cancer Research. 70(8_Supplement). 4289–4289. 1 indexed citations
13.
Moran, Paul, Wěi Li, Bin Fan, et al.. (2006). Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin. Journal of Biological Chemistry. 281(41). 30439–30446. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026